Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
This article compares yields from SP 500 funds and multi-asset retirement portfolios, detailing factors that influence income streams.
25,151 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
AST SpaceMobile surged last month, with spacemobile stock zoomed 53.5% sparking investor chatter. This article breaks...
In a striking contrast, Nancy Pelosi buys bullish calls on Amazon as Berkshire Hathaway scales back its Amazon exposu...
As 2026 unfolds, investors are watching novavax (nvax) 2026 earnings for clarity on demand, pipeline milestones, and ...
Coinbase is piloting a daring new product set that lets traders speculate on private company IPO futures before the s...
I’m a fan of Costco as a retailer, but my investing stance is stubbornly conservative. Here’s the core reason haven't...
Investors are buzzing about Uber stock soaring? as the company moves toward stronger profitability and disciplined gr...
Netskope swung after its latest earnings, leaving investors wondering why the stock crashed today. This guide breaks ...
Teladoc has faced a challenging stretch after its pandemic boom. This guide examines whether teladoc stock going read...
What’s going with stock? AMD is riding a data center and AI wave. This guide breaks down the drivers, risks, and real...
Nebius Group stunned investors with a strong May, signaling momentum in its AI cloud push. This guide breaks down wha...
DAIO's Q4 2025 earnings offer more than headlines. This in-depth look translates the transcript into actionable insig...